Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, S. M.
NEUROLOGY 1998;51:690-694
© 1998 American Academy of Neurology

Cerebral amyloid angiopathy

Prospects for clinical diagnosis and treatment

Steven M. Greenberg, MD, PhD

From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Address correspondence and reprint requests to Massachusetts General Hospital, Wang Ambulatory Care Center 836, Boston, MA 02114.

This article reviews diagnosis of cerebral amyloid angiopathy (CAA) during life and possible approaches to prevention. A clinical diagnosis of 'probable CAA' can be made in patients aged 60 years or older with multiple hemorrhages confined to lobar brain regions and no other cause of hemorrhage. Gradient-echo MRI facilitates diagnosis by showing previous hemorrhages with high sensitivity. This technique can also mark the progression of CAA, as 50% of studied patients developed new petechial hemorrhages during 1.5 years of follow-up. The apolipoprotein E {varepsilon}2 and {varepsilon}4 alleles are associated with increased risk and earlier age of first hemorrhage, but are neither sensitive nor specific for CAA. The major remaining challenges are to develop new markers for the presence of CAA and treatments to block vascular amyloid deposition and vessel breakdown.


Support by grants from NIH AG00725, the American Heart Association, and the Edward Mallinckrodt, Jr. Foundation.

Received March 4, 1998. Accepted in final form June 5, 1998.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
C. Salvarani, R. D. Brown Jr, K. T. Calamia, T. J. H. Christianson, J. Huston III, J. F. Meschia, C. Giannini, D. V. Miller, and G. G. Hunder
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy
Rheumatology, November 1, 2008; 47(11): 1671 - 1677.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. H. Feldman, L. F. Maia, I. R.A. Mackenzie, B. B. Forster, J. Martzke, and A. Woolfenden
Superficial Siderosis: A Potential Diagnostic Marker of Cerebral Amyloid Angiopathy in Alzheimer Disease
Stroke, October 1, 2008; 39(10): 2894 - 2897.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. W. Vernooij, A. van der Lugt, M. A. Ikram, P. A. Wielopolski, W. J. Niessen, A. Hofman, G. P. Krestin, and M.M.B. Breteler
Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
Neurology, April 1, 2008; 70(14): 1208 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E.M. Haacke, Z.S. DelProposto, S. Chaturvedi, V. Sehgal, M. Tenzer, J. Neelavalli, and D. Kido
Imaging Cerebral Amyloid Angiopathy with Susceptibility-Weighted Imaging
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 316 - 317.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. Cabrejo, L. Guyant-Marechal, A. Laquerriere, M. Vercelletto, F. De La Fourniere, C. Thomas-Anterion, C. Verny, F. Letournel, F. Pasquier, A. Vital, et al.
Phenotype associated with APP duplication in five families
Brain, November 1, 2006; 129(11): 2966 - 2976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S.-H. Lee, S.-J. Kwon, K. S. Kim, B.-W. Yoon, and J.-K. Roh
Topographical Distribution of Pontocerebellar Microbleeds
AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1337 - 1341.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. M. Remes, S. Finnila, H. Mononen, H. Tuominen, R. Takalo, R. Herva, and K. Majamaa
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy
Neurology, July 27, 2004; 63(2): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. -H. Lee, J. -M. Park, S. -J. Kwon, H. Kim, Y. H. Kim, J. K. Roh, and B. W. Yoon
Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients
Neurology, July 13, 2004; 63(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. M. Greenberg, J. A. Eng, M. Ning, E. E. Smith, and J. Rosand
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Stroke, June 1, 2004; 35(6): 1415 - 1420.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
U. Oh, R. Gupta, J. W. Krakauer, A. G. Khandji, S. S. Chin, and M. S.V. Elkind
Reversible leukoencephalopathy associated with cerebral amyloid angiopathy
Neurology, February 10, 2004; 62(3): 494 - 497.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. H. Lee, H. J. Bae, S. J. Kwon, H. Kim, Y. H. Kim, B. W. Yoon, and J. K. Roh
Cerebral microbleeds are regionally associated with intracerebral hemorrhage
Neurology, January 13, 2004; 62(1): 72 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Fryer, J. W. Taylor, R. B. DeMattos, K. R. Bales, S. M. Paul, M. Parsadanian, and D. M. Holtzman
Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., August 27, 2003; 23(21): 7889 - 7896.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K.S. Wong, Y.L. Chan, J.Y. Liu, S. Gao, and W. W.M. Lam
Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages
Neurology, February 11, 2003; 60(3): 511 - 513.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, M. Staufenbiel, P. M. Mathews, and M. Jucker
Cerebral Hemorrhage After Passive Anti-Abeta Immunotherapy
Science, November 15, 2002; 298(5597): 1379 - 1379.
[Full Text] [PDF]


Home page
StrokeHome page
H. Kato, M. Izumiyama, K. Izumiyama, A. Takahashi, and Y. Itoyama
Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis
Stroke, June 1, 2002; 33(6): 1536 - 1540.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. T. Winkler, L. Bondolfi, M. C. Herzig, L. Jann, M. E. Calhoun, K.-H. Wiederhold, M. Tolnay, M. Staufenbiel, and M. Jucker
Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy
J. Neurosci., March 1, 2001; 21(5): 1619 - 1627.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. A. Knudsen, J. Rosand, D. Karluk, and S. M. Greenberg
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Neurology, February 27, 2001; 56(4): 537 - 539.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Roob, A. Lechner, R. Schmidt, E. Flooh, H.-P. Hartung, and F. Fazekas
Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage
Stroke, November 1, 2000; 31(11): 2665 - 2669.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Passero, F. Reale, G. Ciacci, and E. Zei
Differing Temporal Patterns of Onset in Subgroups of Patients With Intracerebral Hemorrhage
Stroke, July 1, 2000; 31(7): 1538 - 1544.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Kinoshita, T. Okudera, H. Tamura, T. Ogawa, and J. Hatazawa
Assessment of Lacunar Hemorrhage Associated With Hypertensive Stroke by Echo-Planar Gradient-Echo T2*-Weighted MRI
Stroke, July 1, 2000; 31(7): 1646 - 1650.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. S. Wong, V. Mok, W. W. M. Lam, R. Kay, A. Tang, Y. L. Chan, and J. Woo
Aspirin-associated intracerebral hemorrhage: Clinical and radiologic features
Neurology, June 27, 2000; 54(12): 2298 - 2301.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. R. Caplan and D. N. Louis
Case 10-2000- A 63-Year-Old Man with Changes in Behavior and Ataxia
N. Engl. J. Med., March 30, 2000; 342(13): 957 - 965.
[Full Text] [PDF]


Home page
NEJMHome page
H. C. O'Donnell, J. Rosand, K. A. Knudsen, K. L. Furie, A. Z. Segal, R. I. Chiu, D. Ikeda, and S. M. Greenberg
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
N. Engl. J. Med., January 27, 2000; 342(4): 240 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. E. Van Nostrand, J. P. Melchor, H. S. Cho, S. M. Greenberg, and G. W. Rebeck
Pathogenic Effects of D23N Iowa Mutant Amyloid beta -Protein
J. Biol. Chem., August 24, 2001; 276(35): 32860 - 32866.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.